NEW YORK — This week Johnson & Johnson said that it had begun its large-scale, pivotal, multi-country Phase-3 trial for its COVID-19 vaccine candidate. The company said it expects the first batches of the COVID-19 vaccine, JNJ-78436735, to be available for emergency use authorization in early next year, if proven to be safe and effective.
TRENTON, N.J. — Johnson & Johnson announced Thursday it will start providing the list price of its prescription drugs in upcoming television ads. The company would be the first drugmaker to take that step. The company will start with its popular blood thinner, Xarelto, said Scott White, head of J&J’s North American pharmaceutical marketing. By